申请人:Nihon Medi-Physics Co., Ltd.
公开号:US20140187784A1
公开(公告)日:2014-07-03
It is intended to provide a radioactive compound that has higher selectivity for CYP11B2 than that for CYP11B1, exhibits highly selective accumulation in the adrenal gland compared with blood and organs adjacent to the adrenal gland, and permits commercial supply. The present invention provides a radioactive quinolinone derivative represented by the predetermined general formula or a salt thereof.
本发明旨在提供一种放射性化合物,其对CYP11B2的选择性高于对CYP11B1的选择性,与血液和邻近肾上腺器官相比,在肾上腺腺体中表现出高度选择性的积累,并且可以进行商业供应。本发明提供了由预定一般式表示的放射性喹啉酮衍生物或其盐。